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Glutamate imaging may be capable of identifying the focus of  
epileptic seizures in patients who appear to have nonlesional epilepsy 
on standard imaging techniques, researchers report in Science 
Translational  Medicine. 
The findings are based on just four patients, but the team 
chose to publish the results to speed wider validation of the 
technique, saying that it could lead to substantial  improvements in 
the treatment of patients with drug-resistant epilepsy. 
Because it is well established that patients with lesional 
epilepsy have better surgical outcomes than those with nonlesional 
epilepsy, new neuroimaging techniques capable of detecting subtle 
lesions could potentially improve patient care and increase the 
chance of seizure freedom after surgery. 
The four patients, who all had temporal lobe epilepsy (TLE), 
had been classified as having nonlesional epilepsy based on standard, 
which the team says is the case for about a third of TLE patients. 
Is one patient, magnetic resonance spectroscopy (MRS) 
findings also shoed increased glutamate levels in the ipsilateral 
hippocampus. The other three patients did not have usable MRS 
results, because of motion and susceptibility artefacts. 
One patient underwent right temporal lobectomy, and 
pathological analysis showed hippocampal changes consistent with 
mesial temporal sclerosis. 
Glutamate helps finding the epileptic foci in a specific brain 
region, gives clinicians critical information to guide targeted 
therapies that have the potential to control seizures in patients that 
currently do not have treatment options. 
 
 
 
 
